Study of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast Cancer

NCT00050141 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

121

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: ZARNESTRA, tipifarnib, R115777

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.